Davis JM - Search Results

1

Polygenic risk scores and the need for pharmacotherapy in neonatal abstinence syndrome.

Bibi S, Gaddis N, Johnson EO, Lester BM, Kraft W, Singh R, Terrin N, Adeniyi-Jones S, Davis JM. Bibi S, et al. Among authors: davis jm. Pediatr Res. 2023 Apr;93(5):1368-1374. doi: 10.1038/s41390-022-02243-0. Epub 2022 Aug 16. Pediatr Res. 2023. PMID: 35974158 Free PMC article.

2

Disarray in the perinatal management of neonatal abstinence syndrome.

Lester BM, Davis JM. Lester BM, et al. Among authors: davis jm. Pediatr Res. 2022 Mar;91(4):727-728. doi: 10.1038/s41390-021-01848-1. Epub 2021 Nov 23. Pediatr Res. 2022. PMID: 34815528 No abstract available.

3

Pharmacologic treatment of infants with neonatal abstinence syndrome in community hospitals compared to academic medical centers.

Friedman H, Parkinson G, Tighiouart H, Parkinson C, Tybor D, Terrin N, Lester B, Harvey-Wilkes K, Davis JM. Friedman H, et al. Among authors: davis jm. J Perinatol. 2018 Dec;38(12):1651-1656. doi: 10.1038/s41372-018-0230-8. Epub 2018 Sep 20. J Perinatol. 2018. PMID: 30237476

4

Association of a Simplified Finnegan Neonatal Abstinence Scoring Tool With the Need for Pharmacologic Treatment for Neonatal Abstinence Syndrome.

Devlin LA, Breeze JL, Terrin N, Gomez Pomar E, Bada H, Finnegan LP, O'Grady KE, Jones HE, Lester B, Davis JM. Devlin LA, et al. Among authors: davis jm. JAMA Netw Open. 2020 Apr 1;3(4):e202275. doi: 10.1001/jamanetworkopen.2020.2275. JAMA Netw Open. 2020. PMID: 32267513 Free PMC article.

5

Neonatal Abstinence Syndrome Severity Index Predicts 18-Month Neurodevelopmental Outcome in Neonates Randomized to Morphine or Methadone.

Flannery T, Davis JM, Czynski AJ, Dansereau LM, Oliveira EL, Camardo SA, Lester BM. Flannery T, et al. Among authors: davis jm. J Pediatr. 2020 Dec;227:101-107.e1. doi: 10.1016/j.jpeds.2020.08.034. Epub 2020 Aug 14. J Pediatr. 2020. PMID: 32805259 Free PMC article. Clinical Trial.

6

Escaping the Finnegan - Is it time?

Singh R, Davis JM. Singh R, et al. Among authors: davis jm. Semin Fetal Neonatal Med. 2021 Jun;26(3):101218. doi: 10.1016/j.siny.2021.101218. Epub 2021 Feb 25. Semin Fetal Neonatal Med. 2021. PMID: 33663940

7

Effects of Pharmacologic Treatment for Neonatal Abstinence Syndrome on DNA Methylation and Neurobehavior: A Prospective Cohort Study.

Camerota M, Davis JM, Dansereau LM, Oliveira EL, Padbury JF, Lester BM. Camerota M, et al. Among authors: davis jm. J Pediatr. 2022 Apr;243:21-26. doi: 10.1016/j.jpeds.2021.12.057. Epub 2021 Dec 28. J Pediatr. 2022. PMID: 34971656 Free PMC article.

8

Establishing evidence-based pharmacologic treatments for neonatal abstinence syndrome: A retrospective case study.

Brewer SK, Davis JM, Singh R, Welch LC. Brewer SK, et al. Among authors: davis jm. J Clin Transl Sci. 2022 Jul 25;6(1):e96. doi: 10.1017/cts.2022.431. eCollection 2022. J Clin Transl Sci. 2022. PMID: 36003213 Free PMC article.

9

Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome.

Wachman EM, Hayes MJ, Lester BM, Terrin N, Brown MS, Nielsen DA, Davis JM. Wachman EM, et al. Among authors: davis jm. J Pediatr. 2014 Sep;165(3):472-8. doi: 10.1016/j.jpeds.2014.05.040. Epub 2014 Jul 1. J Pediatr. 2014. PMID: 24996986 Free PMC article.

10

Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant.

Kraft WK, Stover MW, Davis JM. Kraft WK, et al. Among authors: davis jm. Semin Perinatol. 2016 Apr;40(3):203-12. doi: 10.1053/j.semperi.2015.12.007. Epub 2016 Jan 12. Semin Perinatol. 2016. PMID: 26791055 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,141 results

Search Page

Filters